Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

Lung cancer (LC) is one of the most common causes of death worldwide. The identification of oncogene-addicted driving mutations suitable for targeted therapy has improved clinical outcomes in advanced diseases. Clinical trials, on the other hand, rarely involve vulnerable groups such as pregnant wom...

Descripción completa

Detalles Bibliográficos
Autores principales: Soberanis Pina, Pamela, Lara-Mejía, Luis, Matias-Cruz, Venecia, Barrón, Feliciano, Cardona, Andrés F., Raez, Luis E., Rios-Garcia, Eduardo, Arrieta, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079944/
https://www.ncbi.nlm.nih.gov/pubmed/37035182
http://dx.doi.org/10.3389/fonc.2023.1108124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079944/
https://www.ncbi.nlm.nih.gov/pubmed/37035182
http://dx.doi.org/10.3389/fonc.2023.1108124

Ejemplares similares